In order to promote the all-round development of primary oncology medicine and further improve the diagnosis and treatment of primary tumor diseases, the Chengdu High-tech Medical Association held online on January 24, 2022 the "2022 Life Journey Anti-Cancer Series Academic Activities-Western Tour Lectures (Esophageal Cancer 1)" , this forum invited well-known experts in related fields to give lectures on esophageal tumor immunotherapy and other related content, and to share the latest research progress.

This conference provides a platform for clinical doctors and scientific researchers to exchange diagnosis and treatment technology and academic research results, which is conducive to academic discussions and exchanges of classic cases and cutting-edge technologies in the promotion of tumor immunity, and establishes comprehensive and standardized treatment of oncology medicine. concept. It is of great significance to promote high-quality clinical research in the field of medical oncology and promote the level of clinical scientific research.